Skip to main content
All inhalers

ASMANEX TWISTHALER

Mometasone

ASMANEX TWISTHALER

ICS DPI

Mometasone furoate · Organon

Clinical Reference

Active Medication & Mechanism

  • Mometasone furoate ICS
    110 mcg or 220 mcg per actuation (delivers 100 mcg or 200 mcg from mouthpiece)

    Synthetic corticosteroid with potent anti-inflammatory properties. Reduces airway inflammation.

FDA-Approved Dosing by Indication

// approval varies by strength + age
Asthma
3/4 approved regimens
  • 110 mcg FDA Approved
    Pop · Patients ≥4 years (previously on bronchodilators alone or ICS)
    1 inhalation once daily in the evening
    For patients 4–11 years, maximum dose is 110 mcg once daily in the evening.
    Total · 110 mcg
  • 220 mcg FDA Approved
    Pop · Patients ≥12 years (previously on bronchodilators alone or ICS)
    1 inhalation once daily in the evening or 1 inhalation twice daily
    Recommended starting dose for patients ≥12 years previously on bronchodilators alone or inhaled corticosteroids.
    Total · 220–440 mcg
  • 220 mcg FDA Approved
    Pop · Patients ≥12 years (previously on oral corticosteroids)
    2 inhalations twice daily
    Maximum recommended dose. For patients previously on oral corticosteroids.
    Total · 880 mcg
  • Any strength Not Approved
    Pop · Acute bronchospasm
    Total · Not a bronchodilator. Not for relief of acute bronchospasm. Use a SABA.
Acute Use
0/1 approved regimens
  • Any strength Not Approved
    Pop · Acute bronchospasm / rescue
    Total · Not for acute use. Use a SABA.

For clinical reference only. This workspace is intended for use by qualified healthcare professionals and is not a substitute for clinical judgement, prescribing information, or product monographs. Always verify doses and indications against the most current labelling before prescribing.

Inhaler Database · © inhalerdatabase.com 2024–2026 — All rights reserved